TransMedics Group Inc. (TMDX)
69.43
-6.89 (-9.03%)
At close: Mar 03, 2025, 3:59 PM
67.50
-2.78%
Pre-market: Mar 04, 2025, 07:25 AM EST
TransMedics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
120
Upside
72.83
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Date |
Mike Matson (0.02)
| Needham | Hold | Reiterates | n/a | Feb 5, 2025 |
Allen Gong (0)
| JP Morgan | Hold | Downgrades | 116 75 | Dec 17, 2024 |
Matt O'Brien (0)
| Piper Sandler | Buy | Maintains | 110 90 | Dec 11, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.